AK

Amul Kumar

Active Director Director DIN 06450975
DIN 06450975 First appointment Dec 2012 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2012
Shareholding value •••• Premium profile

About Amul Kumar

Data last updated:

Amul Kumar is a Director at Novosol Pharmaceuticals Private Limited (since 2012). The company operates in Trading. Novosol Pharmaceuticals Private Limited reported revenue of ₹5.3 Lakh (FY 2016).

DIN 06450975
Primary Designation Director
Industry Trading
First Appointment 13 Dec 2012
Oldest Company Age 13 yrs
Largest company Novosol Pharmaceuticals Private Limited · ₹5.3 Lakh (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Dec 20122012₹5.3 Lakh (FY 2016)Active

Board colleagues of Amul Kumar

Directorship timeline

Open interactive timeline →
Novosol Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amul Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amul Kumar

Amul Kumar currently holds 1 directorship: Novosol Pharmaceuticals Private Limited (Director, since 13 Dec 2012, revenue ₹5.3 Lakh (FY 2016)).

Amul Kumar was first appointed on 13 Dec 2012 as Director at Novosol Pharmaceuticals Private Limited.

The current boards of Amul Kumar's companies include Urmila Upadhyay (Novosol Pharmaceuticals Private Limited), Yogendra Singh (Novosol Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available